NEXGEL (NASDAQ:NXGL) & MiMedx Group (NASDAQ:MDXG) Head-To-Head Review

NEXGEL (NASDAQ:NXGLGet Rating) and MiMedx Group (NASDAQ:MDXGGet Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, institutional ownership, dividends, valuation and risk.

Insider & Institutional Ownership

1.9% of NEXGEL shares are owned by institutional investors. Comparatively, 56.6% of MiMedx Group shares are owned by institutional investors. 25.2% of NEXGEL shares are owned by insiders. Comparatively, 19.6% of MiMedx Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Earnings & Valuation

This table compares NEXGEL and MiMedx Group’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NEXGEL $1.55 million 5.00 -$4.31 million N/A N/A
MiMedx Group $258.61 million 1.49 -$10.28 million ($0.30) -11.30

NEXGEL has higher earnings, but lower revenue than MiMedx Group.

Analyst Ratings

This is a breakdown of recent ratings for NEXGEL and MiMedx Group, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NEXGEL 0 0 1 0 3.00
MiMedx Group 0 0 2 0 3.00

NEXGEL presently has a consensus price target of $5.00, suggesting a potential upside of 259.71%. MiMedx Group has a consensus price target of $7.50, suggesting a potential upside of 121.24%. Given NEXGEL’s higher possible upside, research analysts plainly believe NEXGEL is more favorable than MiMedx Group.


This table compares NEXGEL and MiMedx Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
NEXGEL -278.85% -57.42% -40.92%
MiMedx Group -12.44% N/A -18.45%


MiMedx Group beats NEXGEL on 6 of the 10 factors compared between the two stocks.


(Get Rating)

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.

About MiMedx Group

(Get Rating)

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a semi-permeable protective barrier membrane product used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a semi-permeable protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications; and AMNIOBURN a semi-permeable protective barrier allograft used in the treatment of partial-thickness and full-thickness burns, as well as lead product includes mdHACM, a micronized form of AMNIOFIX, supplied in powder form. The company's products have applications primarily in the areas of wound care, burn, surgical, and non-operative sports medicine sectors of healthcare. It also sells allografts for dental applications on an original equipment manufacturer basis. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. is headquartered in Marietta, Georgia.

Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with's FREE daily email newsletter.